Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors

Details for Australian Patent Application No. 2004240771 (hide)

Owner Wilex AG

Inventors Burgle, Markus; Sperl, Stefan; Schmalix, Wolfgang; Clement, Bernd; Wosikowski, Katja

Agent Davies Collison Cave

Pub. Number AU-B-2004240771

PCT Pub. Number WO2004/103984

Priority 103 23 898.0 26.05.03 DE

Filing date 26 May 2004

Wipo publication date 2 December 2004

Acceptance publication date 19 February 2009

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07D 295/185 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/103984 Priority application(s): WO2004/103984

19 February 2009 Application Accepted

  Published as AU-B-2004240771

18 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240772-Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors

2004240766-Metal chelate complexes immobilized on solid supports for peptide preparation